Zimmer Biomet Holdings (ZBH) Equity Average (2009 - 2026)

Zimmer Biomet Holdings' Equity Average history runs 18 years deep, the most recent figure standing at $12.7 billion for Q1 2026.

• In Q1 2026, Equity Average rose 2.04% year-over-year to $12.7 billion; the TTM figure through Mar 2026 stood at $12.7 billion (up 2.04% YoY), while the FY2025 annual figure was $12.6 billion, up 0.87% from the prior year.
• Equity Average was $12.7 billion for Q1 2026 at Zimmer Biomet Holdings, roughly flat from $12.7 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $12.7 billion in Q4 2025 to a low of $12.1 billion in Q2 2022.
• Historically, Equity Average has averaged $12.4 billion across 5 years, with a median of $12.4 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Equity Average fell 4.34% in 2022, then grew 3.76% in 2024.
• A 5-year view of Equity Average shows it stood at $12.1 billion in 2022, then climbed by 3.0% to $12.5 billion in 2023, then slipped by 0.59% to $12.4 billion in 2024, then climbed by 2.43% to $12.7 billion in 2025, then dropped by 0.29% to $12.7 billion in 2026.
• The last three Equity Average figures came in at $12.7 billion (Q1 2026), $12.7 billion (Q4 2025), and $12.6 billion (Q3 2025), per Business Quant data.